BF 2649 hydrochloride

Pricing Availability   Qty
说明: Potent and selective H3 inverse agonist
化学名: 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]-piperidine hydrochloride
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for BF 2649 hydrochloride

BF 2649 hydrochloride is a potent and selective histamine H3 receptor inverse agonist (EC50 = 1.5 nM, Ki = 0.16 nM). Exhibits nootropic effects in cognitive disorders; reduces locomotor hyperactivity induced by methamphetamine. Brain penetrant.

化合物库 for BF 2649 hydrochloride

BF 2649 hydrochloride is also offered as part of the Tocriscreen 2.0 Max. 了解 Tocris 化合物库的更多信息。

技术数据 for BF 2649 hydrochloride

分子量 332.31
公式 C17H26ClNO.HCl
储存 Desiccate at RT
纯度 ≥98% (HPLC)
CAS Number 903576-44-3
PubChem ID 11551689
InChI Key XLFKECRRMPOAQS-UHFFFAOYSA-N
Smiles ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1.Cl

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for BF 2649 hydrochloride

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
water 33.23 100
DMSO 33.23 100

制备储备液 for BF 2649 hydrochloride

以下数据基于产品分子量 332.31。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 3.01 mL 15.05 mL 30.09 mL
5 mM 0.6 mL 3.01 mL 6.02 mL
10 mM 0.3 mL 1.5 mL 3.01 mL
50 mM 0.06 mL 0.3 mL 0.6 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for BF 2649 hydrochloride

分析证书/产品说明书
选择另一批次:

参考文献 for BF 2649 hydrochloride

参考文献是支持产品生物活性的出版物。

Ligneau et al (2007) Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem.Pharmacol. 73 1215 PMID: 17343831

Ligneau et al (2007) BF2.649 [1-{3-{3-(4-chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist/antagonist at the human histamine H3 receptor: Preclinical pharmacology. J.Pharm.Exp.Ther. 320 365 PMID: 17005916


If you know of a relevant reference for BF 2649 hydrochloride, please let us know.

按标靶查看相关产品

按产品操作查看相关产品

查看全部 Histamine H3 Receptor Inverse Agonists

关键词: BF 2649 hydrochloride, BF 2649 hydrochloride supplier, BF2649, HCl, histamine, receptor, H3, histaminergic, antagonists, inverse, agonists, nootropic, Histamine, Receptors, 3743, Tocris Bioscience

篇 BF 2649 hydrochloride 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 BF 2649 hydrochloride 的引用文献。 您是否知道使用了 Tocris BF 2649 hydrochloride 的优秀论文? 请告知我们.

BF 2649 hydrochloride 的评论

目前没有该产品的评论。 Be the first to review BF 2649 hydrochloride and earn rewards!

Have you used BF 2649 hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Histamine Receptors Scientific Review

Histamine Receptors Scientific Review

Written by Iwan de Esch and Rob Leurs, this review provides a synopsis of the different histamine receptor subtypes and the ligands that act upon them; compounds available from Tocris are listed.

Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.